• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的分子损伤:mTOR驱动衰老的一个论据。

Molecular damage in cancer: an argument for mTOR-driven aging.

作者信息

Blagosklonny Mikhail V

机构信息

Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

出版信息

Aging (Albany NY). 2011 Dec;3(12):1130-41. doi: 10.18632/aging.100422.

DOI:10.18632/aging.100422
PMID:22246147
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3273893/
Abstract

Despite common belief, accumulation of molecular damage does not play a key role in aging. Still, cancer (an age-related disease) is initiated by molecular damage. Cancer and aging share a lot in common including the activation of the TOR pathway. But the role of molecular damage distinguishes cancer and aging. Furthermore, an analysis of the role of both damage and aging in cancer argues against "a decline, caused by accumulation of molecular damage" as a cause of aging. I also discuss how random molecular damage, via rounds of multiplication and selection, brings about non-random hallmarks of cancer.

摘要

尽管人们普遍认为,分子损伤的积累在衰老过程中并不起关键作用。然而,癌症(一种与年龄相关的疾病)却是由分子损伤引发的。癌症和衰老有许多共同之处,包括TOR通路的激活。但分子损伤在癌症和衰老中所起的作用有所不同。此外,对损伤和衰老在癌症中的作用进行分析后发现,“由分子损伤积累导致的衰退”作为衰老原因的观点并不成立。我还将探讨随机分子损伤如何通过多轮增殖和选择产生癌症的非随机特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d324/3273893/2cf458f0bd4d/aging-03-1130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d324/3273893/2cf458f0bd4d/aging-03-1130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d324/3273893/2cf458f0bd4d/aging-03-1130-g001.jpg

相似文献

1
Molecular damage in cancer: an argument for mTOR-driven aging.癌症中的分子损伤:mTOR驱动衰老的一个论据。
Aging (Albany NY). 2011 Dec;3(12):1130-41. doi: 10.18632/aging.100422.
2
Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition.衰老与不朽:准程序性衰老及其药物抑制
Cell Cycle. 2006 Sep;5(18):2087-102. doi: 10.4161/cc.5.18.3288. Epub 2006 Sep 15.
3
Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging.细胞周期停滞并非衰老,衰老不仅仅是细胞周期停滞:关于TOR驱动衰老的术语。
Aging (Albany NY). 2012 Mar;4(3):159-65. doi: 10.18632/aging.100443.
4
Metabolic features and regulation in cell senescence.细胞衰老过程中的代谢特征和调控。
BMB Rep. 2019 Jan;52(1):5-12. doi: 10.5483/BMBRep.2019.52.1.291.
5
A senescence secretory switch mediated by PI3K/AKT/mTOR activation controls chemoprotective endothelial secretory responses.由PI3K/AKT/mTOR激活介导的衰老分泌开关控制化学保护性内皮分泌反应。
Genes Dev. 2016 Aug 15;30(16):1811-21. doi: 10.1101/gad.284851.116. Epub 2016 Aug 26.
6
A Systems Biology Roadmap to Decode mTOR Control System in Cancer.癌症中 mTOR 控制系统的系统生物学研究路线图
Interdiscip Sci. 2020 Mar;12(1):1-11. doi: 10.1007/s12539-019-00347-6. Epub 2019 Sep 17.
7
Metformin and rapamycin are master-keys for understanding the relationship between cell senescent, aging and cancer.二甲双胍和雷帕霉素是理解细胞衰老、老化与癌症之间关系的关键。
Aging (Albany NY). 2013 May;5(5):337-8. doi: 10.18632/aging.100561.
8
Effect of the Notch1-mediated PI3K-Akt-mTOR pathway in human osteosarcoma. Notch1 介导的 PI3K-Akt-mTOR 通路对人骨肉瘤的影响。
Aging (Albany NY). 2021 Sep 8;13(17):21090-21101. doi: 10.18632/aging.203261.
9
Cell cycle arrest is not senescence.细胞周期停滞并非衰老。
Aging (Albany NY). 2011 Feb;3(2):94-101. doi: 10.18632/aging.100281.
10
The PI3K/Akt/mTOR pathway regulates the replicative senescence of human VSMCs.PI3K/Akt/mTOR信号通路调节人血管平滑肌细胞的复制性衰老。
Mol Cell Biochem. 2016 Nov;422(1-2):1-10. doi: 10.1007/s11010-016-2796-9. Epub 2016 Sep 13.

引用本文的文献

1
The paradoxical activity of BRAF inhibitors: potential use in wound healing.BRAF抑制剂的矛盾活性:在伤口愈合中的潜在用途。
Arch Dermatol Res. 2025 Jan 28;317(1):311. doi: 10.1007/s00403-024-03785-5.
2
Mikhail 'Misha' Blagosklonny's enduring legacy in geroscience: the hyperfunction theory and the therapeutic potential of rapamycin.米哈伊尔·“米沙”·布拉戈克隆尼在老年科学领域的不朽遗产:功能亢进理论与雷帕霉素的治疗潜力。
Aging (Albany NY). 2025 Jan 12;17(1):1-15. doi: 10.18632/aging.206189.
3
Does Aging Activate T-cells to Reduce Bone Mass and Quality?

本文引用的文献

1
KRAS alleles: the LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel.KRAS 等位基因:NCI-60 面板中的 LCS6 3'UTR 变异和 KRAS 编码序列突变。
Cell Cycle. 2012 Jan 15;11(2):361-6. doi: 10.4161/cc.11.2.18794.
2
Target of rapamycin (TOR) in nutrient signaling and growth control.雷帕霉素靶蛋白(TOR)在营养信号和生长控制中的作用。
Genetics. 2011 Dec;189(4):1177-201. doi: 10.1534/genetics.111.133363.
3
Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks.核糖体蛋白 S6 激酶(S6K)在 mTOR 信号网络中的调节和功能。
衰老是否会激活 T 细胞,从而减少骨量和骨质量?
Curr Osteoporos Rep. 2022 Oct;20(5):326-333. doi: 10.1007/s11914-022-00745-8. Epub 2022 Aug 31.
4
Hallmarks of cancer and hallmarks of aging.癌症的特征和衰老的特征。
Aging (Albany NY). 2022 May 9;14(9):4176-4187. doi: 10.18632/aging.204082.
5
Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin.RB 和 CDKN2A 缺陷的癌细胞对雷帕霉素的凋亡作用有抗性。
Cancer Lett. 2021 Dec 1;522:164-170. doi: 10.1016/j.canlet.2021.09.020. Epub 2021 Sep 23.
6
Paradoxes of senolytics.衰老细胞清除剂的悖论。
Aging (Albany NY). 2018 Dec 28;10(12):4289-4293. doi: 10.18632/aging.101750.
7
Suppression of mTORC1 activity in senescent Ras-transformed cells neither restores autophagy nor abrogates apoptotic death caused by inhibition of MEK/ERK kinases.抑制衰老的Ras转化细胞中的mTORC1活性既不能恢复自噬,也不能消除由抑制MEK/ERK激酶引起的凋亡性死亡。
Aging (Albany NY). 2018 Nov 27;10(11):3574-3589. doi: 10.18632/aging.101686.
8
Targeted elimination of senescent Ras-transformed cells by suppression of MEK/ERK pathway.通过抑制MEK/ERK途径靶向清除衰老的Ras转化细胞。
Aging (Albany NY). 2017 Nov 14;9(11):2352-2375. doi: 10.18632/aging.101325.
9
From rapalogs to anti-aging formula.从雷帕霉素类似物到抗衰老配方。
Oncotarget. 2017 May 30;8(22):35492-35507. doi: 10.18632/oncotarget.18033.
10
MicroRNAs and the metabolic hallmarks of aging.微小 RNA 与衰老的代谢特征。
Mol Cell Endocrinol. 2017 Nov 5;455:131-147. doi: 10.1016/j.mce.2016.12.021. Epub 2017 Jan 3.
Biochem J. 2012 Jan 1;441(1):1-21. doi: 10.1042/BJ20110892.
4
Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.肿瘤相关成纤维细胞中的线粒体氧化应激驱动乳酸生成,促进乳腺癌肿瘤生长:了解衰老与癌症的联系。
Cell Cycle. 2011 Dec 1;10(23):4065-73. doi: 10.4161/cc.10.23.18254.
5
Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.表观遗传学与遗传学。microRNAs 走向临床:验证和靶向 microRNAs 治疗癌症的进展。
Nat Rev Cancer. 2011 Nov 24;11(12):849-64. doi: 10.1038/nrc3166.
6
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice.雷帕霉素可延长近交系雌性小鼠的寿命并抑制自发性肿瘤发生。
Cell Cycle. 2011 Dec 15;10(24):4230-6. doi: 10.4161/cc.10.24.18486.
7
Rapamycin passes the torch: a new generation of mTOR inhibitors.雷帕霉素传递火炬:新一代 mTOR 抑制剂。
Nat Rev Drug Discov. 2011 Oct 31;10(11):868-80. doi: 10.1038/nrd3531.
8
Deciphering the role of nuclear factor-κB in cellular senescence.解读核因子-κB在细胞衰老中的作用。
Aging (Albany NY). 2011 Oct;3(10):913-9. doi: 10.18632/aging.100390.
9
More than just a focus: The chromatin response to DNA damage and its role in genome integrity maintenance.不只是焦点:DNA 损伤的染色质反应及其在基因组完整性维持中的作用。
Nat Cell Biol. 2011 Oct 3;13(10):1161-9. doi: 10.1038/ncb2344.
10
mTOR signaling in disease.mTOR 信号通路与疾病。
Curr Opin Cell Biol. 2011 Dec;23(6):744-55. doi: 10.1016/j.ceb.2011.09.003. Epub 2011 Sep 29.